- Report
- March 2024
- 194 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- April 2024
- 159 Pages
Global
From €5260EUR$5,450USD£4,512GBP
- Report
- January 2024
- 285 Pages
Global
€4821EUR$4,995USD£4,136GBP
- Report
- August 2023
- 74 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- February 2020
- 241 Pages
Japan, United States, ... Japan, United States, Europe, Global
From €4343EUR$4,500USD£3,726GBP
The Herpes Marker market is a subset of the larger Infectious Disease Testing market. It is focused on the detection of the herpes simplex virus (HSV) and other related viruses. Herpes Marker tests are used to diagnose and monitor the progression of the virus, as well as to determine the effectiveness of treatments. Tests are available in both laboratory and point-of-care settings, and can be used to detect HSV-1, HSV-2, and other related viruses.
Herpes Marker tests are used in a variety of clinical settings, including primary care, obstetrics and gynecology, and dermatology. They are also used in research settings to study the epidemiology of the virus.
Some companies in the Herpes Marker market include Abbott, Bio-Rad, Roche, Siemens, and Thermo Fisher Scientific. Show Less Read more